Late TGA run sees success for BI, Janssen

By Megan Brodie 4 years ago | In Products, Regulatory
  • 4 years ago

21 December 2022 The TGA has approved a label expansion for Boehringer Ingelheim’s JARDIANCE (empagliflozin),…

This is subscriber-only content. Please login to continue reading.

Recent News

Top Reads